Screener
TransMedics Group, Inc. TMDX Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from TransMedics Group, Inc.’s reported figures.
The source filing: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206453
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cost of net product revenue | 24,308 | 16,312 |
| Cost of service revenue | 48,464 | 38,997 |
| Total cost of revenue | 72,772 | 55,309 |
| Gross profit | 101,161 | 88,228 |
| Operating expenses: | ||
| Research, development and clinical trials | 24,879 | 17,160 |
| Selling, general and administrative | 62,985 | 43,625 |
| Total operating expenses | 87,864 | 60,785 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is TransMedics Group, Inc.'s gross profit?
- TransMedics Group, Inc. (TMDX) reported gross profit of $101.16M in Q1 2026.
- How has TransMedics Group, Inc.'s gross profit changed year-over-year?
- TransMedics Group, Inc.'s gross profit increased by 14.7% year-over-year, from $88.23M to $101.16M.
- What is the long-term trend for TransMedics Group, Inc.'s gross profit?
- Over 4 years (2021 to 2025), TransMedics Group, Inc.'s gross profit has grown at a 103.5% compound annual growth rate (CAGR), from $21.16M to $362.81M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about TransMedics Group, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude